Citation Impact
Citing Papers
Platelet gene expression and function in patients with COVID-19
2020 Standout
Graft microvascular disease in solid organ transplantation
2014 StandoutNobel
Static platelet adhesion, flow cytometry and serum TXB2 levels for monitoring platelet inhibiting treatment with ASA and clopidogrel in coronary artery disease: a randomised cross-over study
2009 StandoutNobel
Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
2008
What is polypharmacy? A systematic review of definitions
2017 Standout
Pharmacokinetic Drug Interactions of Vinca Alkaloids: Summary of Case Reports
1998
Glutamate receptor ion channels
2005 Standout
Glutamate Receptor Ion Channels: Structure, Regulation, and Function
2010 Standout
Mechanisms of Thrombus Formation
2008 Standout
The Pharmacology of a New Nitric Oxide Donor: B-NOD
2000 StandoutNobel
Mycophenolic acid counteracts B cell proliferation and plasmablast formation in patients with systemic lupus erythematosus
2012
Clinically Important Drug Interactions with Anticoagulants
1996
Atopic dermatitis
2003 Standout
Assessment of laboratory assays to measure rivaroxaban – an oral, direct factor Xa inhibitor
2010
Adverse Health Effects of Marijuana Use
2014 Standout
Effect of Immunosuppression on T-Helper 2 and B-Cell Responses to Influenza Vaccination
2015 StandoutNobel
FLUID RESUSCITATION IN SEVERE SEPSIS AND SEPTIC SHOCK
2007
Avoidance of Bleeding During Surgery in Patients Receiving Anticoagulant and/or Antiplatelet Therapy
2004
Appropriate use of antiplatelets: is prescription in daily practice influenced by the global cardiovascular risk?
2005
Nucleotide signalling during inflammation
2014 StandoutNature
Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays
2010 StandoutNobel
Ciprofloxacin
1988
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagulation assays and reversal of anticoagulant activity
2010 Standout
Paraneoplastic Syndromes Involving the Nervous System
2003 Standout
Gene and Protein Expression Profiles of Anti‐ and Pro‐apoptotic Actions of Dopamine,R‐Apomorphine, Green Tea Polyphenol (−)‐Epigallocatechine‐3‐gallate, and Melatonin
2003
Perioperative Management of Antithrombotic Therapy
2012 Standout
Drug targeting to the colon with lectins and neoglycoconjugates
2003
Oral Anticoagulant Therapy
2012 Standout
How might physical activity benefit patients with Parkinson disease?
2011
Additive effects between platelet concentrates and desmopressin in antagonizing the platelet glycoprotein IIb/IIIa inhibitor eptifibatide
2005
Albumin–drug interaction and its clinical implication
2013 Standout
Comparative Pharmacodynamics and Pharmacokinetics of Oral Direct Thrombin and Factor Xa Inhibitors in Development
2008
Role of intestinal P-glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine*
1997 Standout
Taming THC: potential cannabis synergy and phytocannabinoid‐terpenoid entourage effects
2011 Standout
Cyclosporine markedly raises the plasma concentrations of repaglinide
2005
Outcomes at 6 months for the direct comparison of tirofiban and abciximab during percutaneous coronary revascularisation with stent placement: the TARGET follow-up study
2002
Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation
2006
The Toll-like receptor 2/1 (TLR2/1) complex initiates human platelet activation via the src/Syk/LAT/PLCγ2 signalling cascade
2013 StandoutNobel
To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery
2010 Standout
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Clinically Significant Pharmacokinetic Interactions Between Dietary Caffeine and Medications
2000
Pharmacokinetics and Pharmacodynamics of Cannabinoids
2003
Mycophenolic Acid Inhibits Syncytium Formation Accompanied by Reduction of gp120 Expression
2005 StandoutNobel
Platelet function and HIV: a case–control study
2010
Pharmacodynamic profile of antiplatelet agents: marked differences between single versus costimulation with platelet activators
2004
Monitoring direct FXa-inhibitors and fondaparinux by Prothrombinase-induced Clotting Time (PiCT): Relation to FXa-activity and influence of assay modifications
2008
Microbially controlled drug delivery to the colon
1990
The diverse CB1and CB2receptor pharmacology of three plant cannabinoids: Δ9‐tetrahydrocannabinol, cannabidiol and Δ9‐tetrahydrocannabivarin
2007 Standout
A Randomized, Placebo-Controlled, Crossover Trial of Cannabis Cigarettes in Neuropathic Pain
2008
Self-administration of cannabinoids by experimental animals and human marijuana smokers
2005
Tipranavir: a novel protease inhibitor for HIV therapy
2009
Mycophenolate mofetil and its mechanisms of action
2000 Standout
The European guideline on management of major bleeding and coagulopathy following trauma: fourth edition
2016 Standout
Green tea and its polyphenolic catechins: Medicinal uses in cancer and noncancer applications
2006 Standout
Clinical Pharmacokinetics of Molsidomine
1996
Effects of the Oral, Direct Factor Xa Inhibitor Rivaroxaban on Platelet‐Induced Thrombin Generation and Prothrombinase Activity1
2007
Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: Status and recommendations The Movement Disorder Society Task Force on rating scales for Parkinson's disease
2004 Standout
Mycophenolate Mofetil in the Therapy of Severe Myasthenia gravis
2001
Polypharmacy and Food–Drug Interactions Among Older Persons: A Review
2012
Possible Involvement of Multiple P-Glycoprotein-Mediated Efflux Systems in the Transport of Verapamil and Other Organic Cations Across Rat Intestine
1995
Transition from argatroban to oral anticoagulation with phenprocoumon or acenocoumarol: effects on prothrombin time, activated partial thromboplastin time, and Ecarin Clotting Time
2004
Abciximab
2003
Coffee and Health: A Review of Recent Human Research
2006 Standout
ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC)
2011 Standout
Intravenous Fluids and Acute Kidney Injury
2017 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Effects of the oral, direct factor Xa inhibitor rivaroxaban on commonly used coagulation assays
2010 StandoutNobel
Protein therapeutics: a summary and pharmacological classification
2007 Standout
Human Cannabinoid Pharmacokinetics
2007 Standout
Involvement of Platelet Activation by P2Y12 Receptor in the Development of Transplant Arteriosclerosis in Mice
2009
Do Aspirin and Other Antiplatelet Drugs Reduce the Mortality in Critically Ill Patients?
2011
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
Management of Parkinson's disease: An evidence-based review
2002
Identification of a high-affinity binding site involved in the transport of endocannabinoids
2005
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Statement for Health Professionals From the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association
2004 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
International Clinical Practice Guidelines for the Treatment of Acute Uncomplicated Cystitis and Pyelonephritis in Women: A 2010 Update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases
2011 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Three Decades of β-Lactamase Inhibitors
2010 Standout
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Desmopressin antagonizes the in vitro platelet dysfunction induced by GPIIb/IIIa inhibitors and aspirin
2003
n–3 Fatty Acids in Patients with Multiple Cardiovascular Risk Factors
2013 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Cannabinoids for Medical Use
2015 Standout
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease
2004 Standout
Mycophenolic Acid Differentially Impacts B Cell Function Depending on the Stage of Differentiation
2011
Human platelets synthesize and express functional tissue factor
2007
Mycophenolate mofetil is effective in the treatment of atopic dermatitis.
2001
Efficacy and Safety of a Novel Once-Daily Extended-Release Ciprofloxacin Tablet Formulation for Treatment of Uncomplicated Urinary Tract Infection in Women
2005
Microbiological and Clinical Aspects of Infection Associated with Stenotrophomonas maltophilia
1998 Standout
Chitosan Chemistry and Pharmaceutical Perspectives
2004 Standout
Clopidogrel reduces post-transplant obliterative bronchiolitis
2013
Works of S. Harder being referenced
Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid.
1989
Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIa
2004
Effects of antiplatelet agents on platelet-induced thrombin generation
2002
Monitoring effects of direct FXa-inhibitors with a new one-step prothrombinase-induced clotting time (PiCT) assay: comparative in vitro investigation with heparin, enoxaparin, fondaparinux and DX 9065a
2007
Pharmacokinetics of pravastatin in heart-transplant patients taking cyclosporin A*
2002
Platelet CD62 expression and PDGFAB secretion in patients undergoing PTCA and treatment with abciximab
2001
The effect of exercise on pharmacokinetics and pharmacodynamics of levodopa
2000
Ciprofloxacin absorption in different regions of the human gastrointestinal tract. Investigations with the hf‐capsule.
1990
Medication review of community-dwelling seniors using intensified home-care service
2011
Pharmacokinetics of oxypolygelatine in healthy volunteers
1999
4-quinolones inhibit biotransformation of caffeine
1988
Interaction Between Quinolones and Caffeine
1987
Investigation of nifedipine absorption in different regions of the human gastrointestinal (GI) tract after simultaneous administration of 13 C- and 12 C-nifedipine
1996
Significant effects of tipranavir on platelet aggregation and thromboxane B2 formation in vitro and in vivo
2007
Pharmacodynamic Profile of Verapamil in Relation to Absolute Bioavailability
1991
Appropriateness and surveillance of medication in a cohort of diabetic patients on polypharmacy
2009
Anti-inflammatory effects of clopidogrel intake in renal transplant patients: Effects on platelet-leukocyte interactions, platelet CD40 ligand expression, and proinflammatory biomarkers
2005
Mycophenolate mofetil impairs transendothelial migration of allogeneic CD4 and CD8 T-cells
1999
Ex vivo?in vitro interaction between aspirin, clopidogrel, and the glycoprotein IIb/IIIa inhibitors abciximab and SR121566A
2000
In Vitro Dose Response to Different GPIIb/IIIa-Antagonists: Inter-Laboratory Comparison of Various Platelet Function Tests
2001
Measurement of theophylline absorption from different regions of the gastro-intestinal tract using a remote controlled durg delivery device
1986
Concentration-effect relationship of delta-9-tetrahydrocannabiol and prediction of psychotropic effects after smoking marijuana.
1997
Pharmacokinetics and pharmacodynamics of molsidomine in patients with liver dysfunction due to congestive heart failure.
1992
Gyrase-inhibitors impair caffeine elimination in man.
1987
Lack of a pharmacokinetic interaction between carvedilol and digitoxin or phenprocoumon
1993
Influence of piroxicam coadministration on pharmacodynamic parameters and the plasma concentration/effect relationship of recombinant hirudin (CGP 39393)
1995
Pharmacodynamics of levodopa coadministered with apomorphine in parkinsonian patients with end-of-dose motor fluctuations.
1998
Interaction between verapamil and vincristine binding to plasma proteins.
1992
Prescription of cardiovascular drugs in outpatient care: a survey of outpatients in a German university hospital.
1998
Effects of flupirtine coadministration on phenprocoumon plasma concentrations and prothrombin time.
1994
Dose response and concentration response relationship of apomorphine in patients with Parkinson's disease and end-of-dose akinesia.
1998